Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Migraine Awareness Week: repurposing drugs to treat debilitating symptoms

Although migraines affect approximately one in seven people worldwide, there is no cure for this debilitating disease. The Migraine Trust hopes to increase understanding of this condition through Migraine Awareness Week. The standard of care for migraine symptoms are primarily medicines repurposed from other indications: beta blockers for high blood pressure, anticonvulsants for epilepsy and antidepressants for depression and anxiety.

Go Top